Walleye Trading’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,538
| Closed | -$58.4K | – | 5015 |
|
|
2023
Q1 | $58.4K | Buy |
+5,538
| New | +$168K | ﹤0.01% | 4029 |
|
|
2022
Q2 | – | Sell |
-1,487
| Closed | -$120K | – | 5499 |
|
|
2022
Q1 | $120K | Buy |
1,487
+740
| +99% | +$110K | ﹤0.01% | 4136 |
|
|
2021
Q4 | $151K | Sell |
747
-1,779
| -70% | -$386K | ﹤0.01% | 4121 |
|
|
2021
Q3 | $681K | Buy |
+2,526
| New | +$607K | ﹤0.01% | 2614 |
|
|
2021
Q1 | – | Sell |
-957
| Closed | -$244K | – | 5134 |
|
|
2020
Q4 | $244K | Buy |
+957
| New | +$247K | ﹤0.01% | 3348 |
|
|
2020
Q2 | – | Sell |
-602
| Closed | -$188K | – | 4487 |
|
|
2020
Q1 | $161K | Buy |
602
+556
| +1,209% | +$172K | ﹤0.01% | 2789 |
|
|
2019
Q4 | $15K | Buy |
+46
| New | +$13.3K | ﹤0.01% | 4027 |
|
|
2019
Q3 | – | Sell |
-268
| Closed | -$98.3K | – | 4307 |
|
|
2019
Q2 | $143K | Buy |
268
+188
| +235% | +$94.3K | ﹤0.01% | 3152 |
|
|
2019
Q1 | $40K | Sell |
80
-158
| -66% | -$93.6K | ﹤0.01% | 3791 |
|
|
2018
Q4 | $117K | Buy |
238
+98
| +70% | +$59.2K | ﹤0.01% | 3802 |
|
|
2018
Q3 | $128K | Buy |
140
+84
| +150% | +$71.7K | ﹤0.01% | 4071 |
|
|
2018
Q2 | $41K | Buy |
+56
| New | +$64.6K | ﹤0.01% | 4290 |
|
|
2018
Q1 | – | Sell |
-1,346
| Closed | -$1.73M | – | 4683 |
|
|
2017
Q4 | $1.21K | Buy |
1,346
+852
| +172% | +$504K | 0.01% | 1753 |
|
|
2017
Q3 | $178 | Buy |
494
+358
| +263% | +$112K | ﹤0.01% | 3311 |
|
|
2017
Q2 | $40 | Sell |
136
-441
| -76% | -$127K | ﹤0.01% | 3954 |
|
|
2017
Q1 | $203 | Buy |
577
+301
| +109% | +$67.7K | ﹤0.01% | 2941 |
|
|
2016
Q4 | $51K | Buy |
276
+142
| +106% | +$28.9K | ﹤0.01% | 3635 |
|
|
2016
Q3 | $35K | Buy |
+134
| New | +$34.5K | ﹤0.01% | 3956 |
|
|
2016
Q2 | – | Sell |
-1,390
| Closed | -$311K | – | 5597 |
|
|
2016
Q1 | $287K | Buy |
1,390
+1,350
| +3,375% | +$259K | ﹤0.01% | 2456 |
|
|
2015
Q4 | $10K | Buy |
+40
| New | +$8.22K | ﹤0.01% | 4724 |
|
|
2015
Q2 | – | Sell |
-139
| Closed | -$23.9K | – | 5043 |
|
|
2015
Q1 | $23K | Sell |
139
-49
| -26% | -$10.1K | ﹤0.01% | 3468 |
|
|
2014
Q4 | $44K | Buy |
188
+34
| +22% | +$7.27K | ﹤0.01% | 3310 |
|
|
2014
Q3 | $28K | Sell |
154
-289
| -65% | -$55.3K | ﹤0.01% | 3428 |
|
|
2014
Q2 | $85 | Buy |
+443
| New | +$78.3K | ﹤0.01% | 2579 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3795 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3750 |
|
Other funds holding NKTR
DTC
MAM
SCM
Walleye Trading's NKTR Position: Q2 2023 in Review
Walleye Trading sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 5,538 shares — an estimated $58.4K sold.
Walleye Trading first reported a position in NKTR in Q2 2014 and held it in 24 quarters. The position peaked at $681K in Q3 2021. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.
- Walleye Trading reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
- Walleye Trading sold 5,538 Nektar Therapeutics shares in Q2 2023, an estimated $58.4K.
- Walleye Trading first reported a position in Nektar Therapeutics in Q2 2014 and held it in 24 quarters.
- Walleye Trading's Nektar Therapeutics position peaked at $681K in Q3 2021.
- 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.
Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.